| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/29/2008 | US20080125457 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders |
| 05/29/2008 | US20080125455 disorders of the central nervous system; cardiovascular disorders; gastrointestinal disorders; diabetes insipidus; sleep apnea; (S)-1-(2,3,7,8-tetrahydrofuro[2,3-g]indol-1-yl)-2-propylamine and (S)-1-[1-(1,2,3,6,7,8-hexahydrocyclopent[g]indolyl)]-2-propylamine |
| 05/29/2008 | US20080125447 Combination Therapy |
| 05/29/2008 | US20080125446 For example, 6-amino-2-(chloro or fluoro)-8-(arylthio(oxo))-9H-purines; complex with Heat Shock Protein 90 (HSP 90); proliferative disorders such as breast cancer |
| 05/29/2008 | US20080125426 7-(4-Chlorophenyl)-4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidine-2-carbonitrile; reversible inhibitors of cysteine proteases S, K, F, L, B; diseases associated with Cathepsin S; antiinflammatory agent, autoimmune diseases; asthma, rheumatoid arthritis, multiple sclerosis, Alzheimer's and Crohn's disease |
| 05/29/2008 | US20080125424 Derivatives of urea and related diamines, methods for their manufacture, and uses therefor |
| 05/29/2008 | US20080125423 N-methyl-N-(1-methyl-1H-indol-3-ylmethyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide as an enzyme inhibitor for both Fab I and Fab K which are used in the biosynthesis of fatty acids; enoyl-acyl-carrier protein renamed Fab 1; bactericides; fungicides; Staphylococcus aureus; antibiotics |
| 05/29/2008 | US20080125422 Use of 5ht4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions |
| 05/29/2008 | US20080125418 Benzimidazole derivatives and their use as kdr kinase protein inhibitors |
| 05/29/2008 | US20080125414 Method of Treatment |
| 05/29/2008 | US20080125413 Antagonist for calcitonin gene related peptide (Cgrp); azepinone ligands; migranes; headaches; 1-[(2-methoxyethyl)-2-oxo-6-phenylazepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide |
| 05/29/2008 | US20080125409 N-tert-butyl-5-(5-methanesulfonylamino-2-pyridyl)-1-(6-methoxy-3-pyridyl)-1H-1,2,4-triazole-3-carboxamide; prophylactic and/or therapeutic agent for ischemic diseases; platelet aggregation suppressant |
| 05/29/2008 | US20080125391 administering to a mammal harboring a tumor which expresses HALRs, a Sindbis virus vector to treat the tumor, and the vector has not been modified to target a tumor-specific cellular determinant, has a preferential affinity for HALRs, a Sindbis virus E2 HALR binding domain; ganciclovir; gene therapy |
| 05/29/2008 | US20080125390 Methods for Modulating Immune and Inflammatory Responses |
| 05/29/2008 | US20080125389 Men1 is a marker and therapeutic target for breast and prostate cancer |
| 05/29/2008 | US20080125384 Simultaneous silencing and restoration of gene function |
| 05/29/2008 | US20080125382 Extracellular superoxide dismutase (EC-SOD) gene delivery to prevent oxidative injury |
| 05/29/2008 | US20080125367 Agents for treatment of HCV and methods of use |
| 05/29/2008 | US20080125366 Insecticidal proteins derived from Bacillus Thuringiensis |
| 05/29/2008 | US20080125354 With triple helix and/or poly-proline type II transition state analog phosphorus based inhibitor comprising a phosphonamide, phosphinic peptide or phosphonate ester; e.g. (R,S)-2-Isopropyl-3-((1-(N-(9-Fluorenylmethoxycarbonyl)amino)-methyl)-adamantyloxyphosphinyl)propanoic acid; antitumor agents |
| 05/29/2008 | US20080124772 Using cytochrome P450 related enzymes comprising high regio- and enantioselectivity for the production of flavor, fragrance, pharmaceutical or bio-control agents |
| 05/29/2008 | US20080124411 nasal strip; and an orally administered composition comprising a tissue-firming agent, a tissue-soothing agent, a tissue lubricant, and an expectorant; for combating snoring |
| 05/29/2008 | US20080124406 Spray Mixture For Soothing A Cow Udder |
| 05/29/2008 | US20080124387 Methods and formulations for enhancing the absorption and decreasing the absorption variability of orally administered drugs, vitamins and nutrients |
| 05/29/2008 | US20080124384 Heteroaryl Substituted Piperazinyl-Pyridine Analogues |
| 05/29/2008 | US20080124383 Delivery to inflamed tissue by injection, implantation, or transdermal patch; prevention of pro-inflammatory cytokines will reduce and/or alleviate inflammation of tendons and soft tissue around carpal and tarsal tunnels; reducing compression of the median nerve and posterior tibial nerve, respectively |
| 05/29/2008 | US20080124379 Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity |
| 05/29/2008 | US20080124363 Nucleotide sequences coding enzymatic polypeptide for use in treatment and prevention of parasitic infections |
| 05/29/2008 | US20080124360 Adenovirus particles with enhanced infectivity of dendritic cells and particles with decreased infectivity of hepatocytes |
| 05/29/2008 | US20080124353 Proteinase k resistant surface protein of neisseria meningitidis |
| 05/29/2008 | US20080124352 Methods to bypass CD4+ cells in the induction of an immune response |
| 05/29/2008 | US20080124351 Proteinase k resistant surface protein of neisseria meningitidis |
| 05/29/2008 | US20080124344 Novel Gene Disruptions, Compositions and Methods Relating Thereto |
| 05/29/2008 | US20080124343 Treatment of Inappropriate Immune Responses |
| 05/29/2008 | US20080124337 Immunoglobulin for use in diagnosis, prevention and treatment of neisserial infection; immunootherapeutics |
| 05/29/2008 | US20080124336 Molecules and Methods for Inhibiting Shedding of KIM-1 |
| 05/29/2008 | US20080124331 Compositions and methods for the diagnosis and treatment of tumor |
| 05/29/2008 | US20080124330 Monoclonal antibody for use in treatment and prevention of cell proliferative disorders; tissue targeted therapy |
| 05/29/2008 | US20080124328 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
| 05/29/2008 | US20080124321 ISOLATED BOVINE IgG HEAVY CHAIN PROTEIN AND ITS USE AS AN ANTIMICROBIAL |
| 05/29/2008 | US20080124313 Nucleotide sequences coding methionyl tRNA synthetase protein for use in identifying modulators for prevention and treatment of bacterial infection |
| 05/29/2008 | US20080124311 Novel pharmaceutical compositions for the treatment of virus infection and cancer |
| 05/29/2008 | US20080124309 Cell Surface Glycoprotein |
| 05/29/2008 | US20080124308 Gene Therapy of Solid Tumours by Means of Retroviral Vectors Pseudotyped With Arenavirus Glycoproteins |
| 05/29/2008 | US20080124307 Method for promoting immunotherapy |
| 05/29/2008 | US20080124306 Vigor Enhancement Via Administration of Pyrimidine Derivatives |
| 05/29/2008 | US20080124304 Using vector transformation to generate cells which produce viral particle for use in medical genetics |
| 05/29/2008 | US20080124286 for enhancing epidermal and/or hair follicle stem cell production, cell renewal, and/or growth of the skin, hair and nails, by topical administration; cyanobacteria and green algae |
| 05/29/2008 | US20080124279 pectin is crosslinked with a metal cation; drug delivery system; treating colon cancer; orally administrable |
| 05/29/2008 | US20080124275 Crystalline Form of Fatty Acid Amide Hydrolase (Faah) |
| 05/29/2008 | US20080124270 Compounds Useful as Metal Chelators |
| 05/28/2008 | EP1925676A1 Method for assay on the effect of vascularization inhibitor |
| 05/28/2008 | EP1925319A1 Pharmaceutical compositions containing sc(fv)2 |
| 05/28/2008 | EP1925315A2 Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation |
| 05/28/2008 | EP1925303A2 Use of Angiotensin II type 1 receptor antagonists for the prevention of stroke, diabetes and/or congestive heart failure |
| 05/28/2008 | EP1635806B1 Method for treating alcoholic hepatitis |
| 05/28/2008 | EP1496898B1 Tyrosine kinase inhibitors |
| 05/28/2008 | EP1494992B1 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 05/28/2008 | EP1485354B1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 05/28/2008 | EP1473305B1 Novel glutamate receptor and utilization thereof |
| 05/28/2008 | EP1424326B1 Fused-polycyclic compounds |
| 05/28/2008 | EP1420020B1 4-oxoimidazolidine-2-spiropiperidine derivative |
| 05/28/2008 | EP1404864A4 Regulation of neuronal function through metabotropic glutamate receptor signaling pathways |
| 05/28/2008 | EP1399155B1 Small molecules useful in the treatment of inflammatory disease |
| 05/28/2008 | EP1343483B1 Transdermal system containing a novel high potency progestagen |
| 05/28/2008 | EP1301604B1 Substrates and assays for beta-secretase activity |
| 05/28/2008 | EP1246925B1 Di- or oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins |
| 05/28/2008 | EP1218360B1 Triazine kinase inhibitors |
| 05/28/2008 | EP1066315B1 Use of inhibitors of mammalian asparaginyl endopeptidase for modulating the immune system |
| 05/28/2008 | EP1005485B1 Therapeutic pulmonary lavage with diluted surfactants |
| 05/28/2008 | EP0854927B1 Human dnase i variants |
| 05/28/2008 | CN101189262A Humanin receptor or humanin-like polypeptide receptor |
| 05/28/2008 | CN101189241A Thienopyridine derivative, quinoline derivative, and quinazoline derivative having c-Met autophosphorylation inhibiting activity |
| 05/28/2008 | CN101189231A Novel cyclic aminophenylalkanoic acid derivative |
| 05/28/2008 | CN101189219A Preventive or remedy for depression or anxiety neurosis |
| 05/28/2008 | CN101189002A Methods for modulating macrophage proliferation in ocular disease using polyamine analogs |
| 05/28/2008 | CN101188949A Egg-derived bone-strengthening composition |
| 05/28/2008 | CN101186605A 2-vinyl-8-hydroxyquinoline derivative, preparation method and application thereof |
| 05/28/2008 | CN101185762A Ciliary neurotrophic factors decorated by polyglycol polymer and preparation method thereof |
| 05/28/2008 | CN101185735A Compound breast-rounding essential oil |
| 05/28/2008 | CN101185727A Traditional Chinese medicine preparation containing ginseng and pilose antler capable of nourishing heart and nourishing kidney |
| 05/28/2008 | CN101185726A Cream shape medicine for treating infantile night sweating symptoms |
| 05/28/2008 | CN101185690A Medicine for preventing and overcoming climate sickness |
| 05/28/2008 | CN101185689A Application of seeds of hovenia acerba extraction in anti-fatigue medicine |
| 05/28/2008 | CN101185683A Cream shape medicine for treating infantile sweatful symptoms |
| 05/28/2008 | CN101185651A Application of 2,3-dihydrogen-3-hydroxymethyl-6-amino-[1,4]-benzoxazin in preparing medicine |
| 05/28/2008 | CN101185649A Levoleucovorin freeze-dried injection agent and preparation method and pharmaceutical use thereof |
| 05/28/2008 | CN101185646A Pharmaceutical compositions of amlodipine and atorvastatin |
| 05/28/2008 | CN101185644A Use of agomelatine in obtaining medicaments intended for the treatment of periventricular leukomalacia |
| 05/28/2008 | CN101185454A Nutrition bread |
| 05/28/2008 | CN100390281C Method for preparing physiologically active IL-18 polypeptide |
| 05/28/2008 | CN100390179C Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 05/28/2008 | CN100390173C Tricyclic compound |
| 05/28/2008 | CN100390164C Isoquinoline compounds and medicinal use thereof |
| 05/28/2008 | CN100390163C 2-(2,6-dioxopiperidin-3-yl)-isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines |
| 05/28/2008 | CN100390158C Novel theterocyclic analogs of diphenylethylene compounds |
| 05/28/2008 | CN100390155C Quinoline and quinoxaline compounds |
| 05/28/2008 | CN100390154C Quinoline and quinoxaline compounds as PDGF-receptor and/or LCK tyrosine kinase inhibitors |
| 05/28/2008 | CN100390151C 1-N-phenylamino-1h-imidazole derivatives as aromatase inhibitors |
| 05/28/2008 | CN100390145C Novel crystalline forms of 4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-a, a-dimethylbenzene acetic acid and its hydrochloride |